This week was a volatile one for the global stock markets. For starters, weak manufacturing data released in China did not help matters. But what spooked markets is US Fed Chairman Ben Bernanke's statement that it would be easing out its bond purchases program going forward. Given that a significant chunk of the recent rally in global stock markets has been a result of too much quantitative easing, such a statement sent shivers down the investors' spine. Japan was the worst hit as it lost 3.5% during the week.
India was the second biggest loser as the Indian stock markets ended the week in the red piling up losses of around 3%. While global cues played a significant role in adversely impacting the indices, certain negative developments with respect to corporate governance in the pharmaceutical sector also took their toll.
Source: Yahoo Finance |
Source: BSE |
For this, the global retailers have sought clarifications from the Department of Industrial Policy and Promotion (DIPP) on whether they could set up warehouses in states which are against the Centre's retail FDI policy. As per the government FDI policy, minimum 50% of the first tranche of the FDI would only have to be invested towards back-end infrastructure. Further a foreign retailer must source 30% of the items that it sells in India from small industries.
Now let us move to some news from the corporate world. Companies continued to declare their results for the quarter ended March 2013 .
Tata Group firm Voltas Ltd announced its financial results for the quarter and year ended March 2013 (4QFY13). The company's consolidated income from operations rose by 1.4% YoY during the quarter. Operating profits were lower by 39.2% YoY and operating profit margins declined from 8.7% in 4QFY12 to 5.2% in 4QFY13. Voltas's net profits fell by a whopping 91.4% YoY. During the financial year 2012-13 (FY13), consolidated sales increased by 6.7% YoY, while net profits surged by 28.2% YoY.
Engineering major Larsen & Toubro announced results for the fourth quarter of FY13. Standalone net sales grew by 9.9% YoY during the quarter. Revenue growth was driven by 9.5% YoY growth in the Engineering & Construction (E&C) business. The Machinery & Industrial products (M&I) division also grew at a healthy pace of 9.3% YoY. Operating profits were down by 4.3% YoY owing to increase in material costs and staff costs. Operating margins declined by 180 bps to 12.1% during the quarter. Net profits declined by 6.9% YoY because of lower growth at operating level and higher interest costs.
Coal India announced results for the quarter ended March 2013. Net sales declined by 21.1% YoY during the quarter. This was largely due to 26.7% decline in production volume and 25% decline in offtake volume. Despite fall in operating expenditure, Coal India reported an operating loss during the quarter as compared to an operating profit in the same quarter last year. However 71.2% YoY growth in other income and decreased depreciation and interest costs helped the company post 89.7% YoY growth in net profits during the quarter. The company also recommended a final dividend of Rs 4.3 per share for FY13. This is over and above the interim dividend of Rs 9.7 per share for FY13.
Company | 17-May-13 | 24-May-13 | Change | 52-wk High/Low | |
Top gainers during the week (BSE-A Group) | |||||
Adani Power | 50 | 57 | 13.2% | 70/37 | |
Oracle Financial Services | 2,419 | 2,590 | 7.0% | 3414/2350 | |
United Spirits | 2,411 | 2,570 | 6.6% | 2586/547 | |
Emami Limited | 692 | 736 | 6.3% | 764/461 | |
Nestle | 4,970 | 5,250 | 5.6% | 5345/4306 | |
Top losers during the week (BSE-A Group) | |||||
Housing Development Infra | 60 | 49 | -18.4% | 124/44 | |
Unitech | 31 | 25 | -17.5% | 41/18 | |
Jaiprakash Associates | 82 | 68 | -17.2% | 107/58 | |
Ranbaxy Labs | 471 | 390 | -17.2% | 578/371 | |
Apollo Hospitals | 1,068 | 901 | -15.6% | 1096/605 |
In some other news, Wockhardt corrected by almost 7% on a single day i.e. Friday. This was because the company received an "import alert" from the USFDA for its manufacturing facility in Waluj near Aurangabad. This is expected to affect Wockhardt's revenues by US$ 100 m annually. The plant is the only injectable plant where the company holds USFDA approval. As on date, the company holds approval of approximately 30-35 injectables.
The Indian stock markets were down by nearly 3% during the week. This was due to global cues as well as concerns in the pharma sector. However, in our opinion, investors should continue investing in fundamentally sound companies whenever these are trading at reasonable valuations.
For information on how to pick stocks that have the potential to deliver big returns, download our special report now!
Read the latest Market Commentary
Equitymaster requests your view! Post a comment on "Volatile week for global stock markets". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!